Craft

Navidea Biopharmaceuticals

Stock Price

$0

2024-10-29

Market Capitalization

$100.1 K

2024-10-29

Revenue

$65.7 K

FY, 2022

Navidea Biopharmaceuticals Summary

Company Summary

Overview
Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Navidea is developing multiple precision diagnostic products and platforms to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making and, ultimately, patient care.
Type
Public
Status
Active
Founded
1983
HQ
Dublin, OH, US | view all locations
Website
http://www.navidea.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

3 locations detected

  • Dublin, OH HQ

    United States

    4995 Bradenton Ave

  • WD

    Ireland

    Kilminnin South, Co. Waterford

  • Thame, England

    United Kingdom

    30 Upper High St

Navidea Biopharmaceuticals Financials

Summary Financials

Net income (Q3, 2023)
($2.3M)
Cash (Q3, 2023)
$3.9M
EBIT (Q3, 2023)
($2.1M)
Enterprise value
($3.8M)

Footer menu